Tech Company Financing Transactions

Synapticure Funding Round

On 2/10/2022, Synapticure landed $6 million in Seed funding from GV, Byers Capital and private investors.

Transaction Overview

Company Name
Announced On
2/10/2022
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Seed
Investors

GV (Lead Investor)

Byers Capital

private investors (Adam Koppel)

private investors (Benjamin Silbermann)

private investors (David Hodgson)

private investors (Divya Silbermann)

private investors (Gerald Bisbee)

private investors (Jeff Huber)

private investors (Joe Kraus)

private investors (Rohan Seth)

private investors (Ron Conway)

Lifeforce Ventures

Martin Ventures

Y Combinator

Proceeds Purpose
The company will use the new capital to rapidly scale its care platform to people living with ALS across the United States.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
2045 W Grand Ave. B
Chicago, IL 60612
USA
Email Address
Not Recorded
Overview
Synapticure is bringing personalized care online and to your home. Built by and for those living with ALS, alongside leading ALS clinicians, to transform care for all people living with ALS.
Profile
Synapticure LinkedIn Company Profile
Social Media
Synapticure Company Twitter Account
Company News
Synapticure News
Facebook
Synapticure on Facebook
YouTube
Synapticure on YouTube

Management Team

Title
Name
Email & Social
Chairman
Jonathan Hirsch
  Jonathan Hirsch LinkedIn Profile  Jonathan Hirsch Twitter Account  Jonathan Hirsch News  Jonathan Hirsch on Facebook
Chairman
Jason Langheier
  Jason Langheier LinkedIn Profile  Jason Langheier Twitter Account  Jason Langheier News  Jason Langheier on Facebook
Chairman
Brian Wallach
  Brian Wallach LinkedIn Profile  Brian Wallach Twitter Account  Brian Wallach News  Brian Wallach on Facebook
Chief Executive Officer
Sandra Abrevaya
  Sandra Abrevaya LinkedIn Profile  Sandra Abrevaya Twitter Account  Sandra Abrevaya News  Sandra Abrevaya on Facebook
Chief Financial Officer
Peter Wallach
  Peter Wallach LinkedIn Profile  Peter Wallach Twitter Account  Peter Wallach News  Peter Wallach on Facebook
Chief Medical Officer
Jinsy Andrews
  Jinsy Andrews LinkedIn Profile  Jinsy Andrews Twitter Account  Jinsy Andrews News  Jinsy Andrews on Facebook
Chief Technical Officer
Graham Spencer
  Graham Spencer LinkedIn Profile  Graham Spencer Twitter Account  Graham Spencer News  Graham Spencer on Facebook
Vice President
Aaron Gitler
  Aaron Gitler LinkedIn Profile  Aaron Gitler Twitter Account  Aaron Gitler News  Aaron Gitler on Facebook
VP - General Counsel
Chris Muller
  Chris Muller LinkedIn Profile  Chris Muller Twitter Account  Chris Muller News  Chris Muller on Facebook
VP - Product Management
Christie Byrne
  Christie Byrne LinkedIn Profile  Christie Byrne Twitter Account  Christie Byrne News  Christie Byrne on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/9/2022: We Are TALA venture capital transaction
Next: 2/10/2022: CertifyOS venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary